Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yaeko Nakajima-Takagi
Institutions:
Institute of Medical Science, The University of Tokyo,
The University of Tokyo
Observed institutions:
Institute of Medical Science, The University of Tokyo,
The University of Tokyo
OpenAlex ID:
A5000238765
Inhibition of TOPORS ubiquitin ligase augments the efficacy of DNA hypomethylating agents through DNMT1 stabilization
2024
·
Satoshi Kaito
, Kazumasa Aoyama
, et al.
·
Nature Communications
·
29
PDF
Tracking clusterin expression in hematopoietic stem cells reveals their heterogeneous composition across the life span
2025
·
Shuhei Koide
, Motohiko Oshima
, et al.
·
Blood
·
11
Correction: Tissue-Restricted Expression of Nrf2 and Its Target Genes in Zebrafish with Gene-Specific Variations in the Induction Profiles
2012
·
Hitomi Nakajima
, Yaeko Nakajima-Takagi
, et al.
·
PLoS ONE
·
8
Polycomb repressive complex 2 insufficiency underlies myeloid leukemia in Down syndrome
2026
·
Yutaro Suzuki
, Yaeko Nakajima-Takagi
, et al.
·
Blood
·
3
Chromatin accessibility in stem cells unveils progressive transcriptional alterations in myelodysplastic syndrome
2025
·
Motohiko Oshima
, Naoya Takayama
, et al.
·
Nature Communications
·
2
PDF
Compromised hematopoiesis and increased DNA damage following non-lethal ionizing radiation of a human hematopoietic system reconstituted in immunodeficient mice
2015
·
Changshan Wang
, Shunsuke Nakamura
, et al.
·
International Journal of Radiation Biology
·
2
PDF
3121 – Transcriptional and Chromatin Landscapes Define Heterogeneous States of Aged Hematopoietic Stem Cells
2026
·
Shuhei Koide
, Claus Nerlov
, et al.
·
Experimental Hematology
3050 – Regulation of Inflammation-related Myeloid Cell Death by Polycomb Repressive Complex 1.1
2025
·
Takanori Fukuta
, Yaeko Nakajima-Takagi
, et al.
·
Experimental Hematology
3183 – PROGRESSIVE IMBALANCE BETWEEN CLU⁺ AND CLU− HSCs DRIVES FUNCTIONAL HEMATOPOIETIC AGING
2025
·
Shuhei Koide
, Motohiko Oshima
, et al.
·
Experimental Hematology
Supplementary Figure S10 from Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity
2023
·
Tze Mun Loo
, Fumitaka Kamachi
, et al.
PDF
Supplementary Figure S3 from Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity
2023
·
Tze Mun Loo
, Fumitaka Kamachi
, et al.
PDF
Supplementary Figure S1 from Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity
2023
·
Tze Mun Loo
, Fumitaka Kamachi
, et al.
Supplementary Figure S6 from Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity
2023
·
Tze Mun Loo
, Fumitaka Kamachi
, et al.
Supplementary Figure S5 from Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity
2023
·
Tze Mun Loo
, Fumitaka Kamachi
, et al.
PDF
Supplementary Figure S9 from Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity
2023
·
Tze Mun Loo
, Fumitaka Kamachi
, et al.
PDF
Supplementary Figure S2 from Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity
2023
·
Tze Mun Loo
, Fumitaka Kamachi
, et al.
Supplementary Figure S4 from Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity
2023
·
Tze Mun Loo
, Fumitaka Kamachi
, et al.
PDF
Supplementary Figure S7 from Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity
2023
·
Tze Mun Loo
, Fumitaka Kamachi
, et al.
Supplementary Figure S8 from Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity
2023
·
Tze Mun Loo
, Fumitaka Kamachi
, et al.
Supplementary Figure S2 from Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity
2023
·
Tze Mun Loo
, Fumitaka Kamachi
, et al.
PDF
Supplementary Figure S1 from Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity
2023
·
Tze Mun Loo
, Fumitaka Kamachi
, et al.
PDF
Data from Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity
2023
·
Tze Mun Loo
, Fumitaka Kamachi
, et al.
Data from Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE2-Mediated Suppression of Antitumor Immunity
2023
·
Tze Mun Loo
, Fumitaka Kamachi
, et al.
Supplementary Data from Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition
2023
·
Ola Rizq
, Naoya Mimura
, et al.
PDF
Data from Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition
2023
·
Ola Rizq
, Naoya Mimura
, et al.
Show more works
View as search
Works count:
26
Citation count:
55
H-index:
3
I10-index:
2
Year
Topic
Type